| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Editorials |
From the Department of Anesthesiology (R.M.B.Jr., E.L.), Baylor College of Medicine, Houston; Department of Pharmacology and Toxicology (B.K.J., N.J.R.), University of Arkansas for Medical Sciences, Little Rock.
Correspondence to Nancy J. Rusch, PhD, Professor and Chair, Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, 4301 W. Markham Street, #611, Little Rock, AR 72205-7199. E-mail nrusch{at}uams.edu
See related article, pages 176–184
Key Words: TREK-1 potassium channel two pore domain vascular smooth muscle cerebral circulation
"We are more alike than unlike, my dear Captain. I have pores, humans have pores." Lieutenant Commander Data, Stardate 41209.2
Before 1996, all known mammalian K+ channels were classified into only two different structural families according to the number of transmembrane (TM) spanning and pore-forming (P) domains in their
subunit. One family is characterized by K+ channels composed of two TM domains and one P domain, and includes the inwardly rectifying and ATP-sensitive K+ channels. The second family represents K+ channels characterized by six or seven TM domains and one P domain, and includes the voltage-gated and Ca2+-activated K+ channels. To form one functional channel for either of these families, four
subunits assemble to establish one K+ permeable pore.
In the mid 1990s, researchers took advantage of the fact that the P domain of each K+ channels pore-forming
subunit is highly conserved across species and represents a common structural motif.1 Genome searches for DNA sequences coding for the P domain revealed a unique K+ channel in yeast and Caenorhabditis elegans that contained two P domains within a single
subunit polypeptide having eight potential TM domains.2 The following year a human K+ channel was cloned that also showed the unique feature of two P domains, but displayed four TM domains in a single
subunit (Figure 1).3 The channel was given the name TWIK-1 (Tandem of P domains in a Weak Inward rectifying K+ channel). Since the cloning of TWIK-1, a total of fifteen genes coding for K+ channels having two P domains (K2P) and four TM domains have been identified and assigned to the KCNK gene family.4 KCNK can be subdivided into six classes of channels: 1) weak inward rectifiers (TWIK-1, TWIK-2, KCNK7); 2) mechano-gated (TREK-1, TREK-2, TRAAK); 3) alkaline-activated (TALK-1, TALK-2, TASK-2), 4) acid-inhibited (TASK-1, TASK-3, TASK-5), 5) halothane-inhibited (THIK-1, THIK-2); and 6) calcium-activated (TRESK). All but KCNK7, KCNK15 (TASK-5), and KCNK12 (THIK-2) have been shown to encode for functional K+ channels in heterologous expression systems.
|
The K2P channels are typically open at negative membrane potentials and, therefore, are often referred to as "leak", "background", or "baseline" K+ channels. They are ubiquitously expressed throughout the body with the brain being a particular rich source, and are postulated to importantly contribute to the resting membrane potential in neurons.4,5 Specific antagonists for the K2P channels are not available, and these channels are typically resistant to conventional inhibitors of K+ channels including tetraethylammonium and 4-aminopyridine. Thus, defining the properties, regulation and function of K2P channels in specific cell types often relies on using multiple approaches to detect the channel protein, identify K+ current of matching phenotype, and alter channel activity using recognized modulators. In this regard, different types of K2P channels can be regulated by protein kinases, changes in internal or external pH, anesthetic agents, heat, stretch, and compounds that alter the curvature of the membrane.5
In this issue of Circulation Research, Blondeau et al6 report that polyunsaturated fatty acids (PUFA), and particularly
-linolenic acid, induce dilation of the basilar artery by activation of TREK-1 (TWIK RElated K) channels (Figure 2). They propose that this event contributes to the neuroprotective effect of PUFA that previously was attributed to the activation of neuronal TREK-1 channels, and subsequently, reduced neuronal excitability.7 Notably, vascular tissues express many K2P channels including TREK-1, the second K2P channel to be cloned.8–11 However, the vasodilator functions of K+ channels have been attributed almost exclusively to earlier classical K+ channels, and only recently has a dilator function of vascular K2P channels been reported. For example, Gurney et al9 concluded that TASK-1 channels are major contributors to the resting membrane potential of the vascular smooth muscle cells (VSMCs) of rabbit pulmonary artery. Recently, Bryan et al8 reported that arachidonic acid activates K+ currents likely belonging to the K2P family in VSMCs of rat middle cerebral arteries, which induces vasodilation of these vessels. The latter report supports the contention of Blondeau and colleagues6 that K2P channels regulate cerebrovascular reactivity as targets of vasoactive lipids. Notably, lipids are known to activate or inhibit TREK-1 channels in nonvascular cells depending on whether they deform the membrane in an outward or inward direction, respectively.5 Lipids including arachidonic acid and other PUFAs that produce an outward curvature result in channel activation,12–14 whereas saturated fatty acids have no effect on TREK-1 activity.15 The regulation of TREK-1 channels by membrane stretch, pH, temperature, signaling molecules and anesthetic agents, and by binding to A kinase anchoring protein, also has been documented.7,12–21
|
The work of Blondeau et al6 gains additional impact by using multiple approaches to characterize the expression of TREK-1 channels in cerebral arteries, and implicating them in the dilator response of the cerebral circulation to PUFA. Initially, immunohistochemistry was used to detect TREK-1 protein in the medial and intimal layers of rat basilar arteries. Interestingly, it was not detected in rat carotid arteries, suggesting site-specific expression. Vascular reactivity assays demonstrated that dilator responses to PUFA also were limited to basilar and not carotid arteries, and several lines of evidence suggested that PUFA–induced dilations relied on K+ efflux. Subsequently, laser-Doppler measurements verified that PUFA increased cerebral blood in anesthetized rats. As a critical test of hypothesis, similar vascular reactivity and laser-Doppler studies were repeated in basilar arteries of TREK-1–/– mice. The findings showed that the dilator response to PUFA was abolished in isolated basilar arteries of TREK-1–/– mice, and the corresponding increase in blood flow in vivo also was abolished. Thus, the study by Blondeau et al6 provides compelling evidence that TREK-1 channels are important mediators of PUFA-induced dilation in the cerebral circulation. Perhaps the only missing piece of evidence is the direct demonstration using patch-clamp techniques of PUFA-induced K+ currents in rat or mouse cerebral endothelial cells or VSMCs. The authors do not establish whether the TREK-1 channels activated by PUFA in the basilar artery are of endothelial or VSMC origin. The TREK-1 channel displays outwardly rectifying currents because of a block of inward current by external Mg2+ and an intrinsic voltage-dependent mechanism.22,23 However, although it displays voltage-dependent gating, it is still considered a "leak" channel because TREK-1 channels are open over a wide voltage range.5
Blondeau et al6 also demonstrated that endothelium-mediated dilations to acetylcholine in basilar arteries were completely abolished in TREK-1–/– mice. This finding complements a recent study by the same group in which endothelium-induced dilations were severely attenuated in the mesenteric arteries of TREK-1–/– mice.24 In the latter study, the deletion of the TREK-1 channel appeared to disrupt signaling between receptors and endothelial NO synthase. This mechanism of endothelial dysfunction appears distinct from the loss of PUFA-induced dilation in the cerebral circulation of TREK-1–/– mice, which did not rely on nitric oxide as a vasodilator. Regardless, the new findings of Blondeau et al6 contribute to the growing body of evidence that TREK-1 channels, as unique members of the K2P family, may mediate several important dilator responses that are critical for the regulation of arterial reactivity in different vascular beds.
| Acknowledgments |
|---|
Research in the authors laboratories was supported in part by USPHS RO1 NS-46666 and PO1 NS-38660 (RMB) and R01 HL-59238 (NJR) from the USA National Institutes of Health. Biny K. Joseph is a predoctoral fellow of the American Heart Association – Heartland Affiliate.
Disclosures
None.
| Footnotes |
|---|
| References |
|---|
|
|
|---|
2. Ketchum KA, Joiner WJ, Sellers AJ, Kaczmarek LK, Goldstein SA. A new family of outwardly rectifying potassium channel proteins with two pore domains in tandem. Nature. 1995; 376: 690–695.[CrossRef][Medline] [Order article via Infotrieve]
3. Lesage F, Guillemare E, Fink M, Duprat F, Lazdunski M, Romey G, Barhanin J. TWIK-1, a ubiquitous human weakly inward rectifying K+ channel with a novel structure. EMBO J. 1996; 15: 1004–1011.[Medline] [Order article via Infotrieve]
4. Goldstein SAN, Bayliss DA, Kim D, Lesage F, Plant LD, Rajan S. International Union of Pharmacology. LV. Nomenclature and molecular relationships of two-P potassium channels. Pharmcaol Rev. 2005; 57: 527–540.[CrossRef]
5. Honore E. The neuronal background K2P channels: focus on TREK1. Nat Rev Neurosci. 2007; 8: 251–261.[Medline] [Order article via Infotrieve]
6. Blondeau N, Pétrault O, Manta S, Giordanengo V, Gounon P, Bordet R, Lazdunski M, Heurteaux C. Polyunsaturated fatty acids are cerebral vasodilators via the TREK-1 potassium channel. Circ Res. 2007; 101: 176–184.
7. Heurteaux C, Guy N, Laigle C, Blondeau N, Duprat F, Mazzuca M, Lang-Lazdunski L, Widmann C, Zanzouri M, Romey G, Lazdunski M. TREK-1, a K+ channel involved in neuroprotection and general anesthesia. EMBO J. 2004; 23: 2684–2695.[CrossRef][Medline] [Order article via Infotrieve]
8. Bryan RM Jr, You J, Phillips SC, Andresen JJ, Lloyd EE, Rogers PA, Dryer SE, Marrelli SP. Evidence for two-pore domain potassium channels in rat cerebral arteries. Am J Physiol Heart Circ Physiol. 2006; 291: H770–H780.
9. Gurney AM, Osipenko ON, MacMillan D, McFarlane KM, Tate RJ, Kempsill FEJ. Two-pore domain K channel, TASK-1, in pulmonary artery smooth muscle cells. Circ Res. 2003; 93: 957–964.
10. Gardener MJ, Johnson IT, Burnham MP, Edwards G, Heagerty AM, Weston AH. Functional evidence of a role for two-pore domain potassium channels in rat mesenteric and pulmonary arteries. Br J Pharmacol. 2004; 142: 192–202.[CrossRef][Medline] [Order article via Infotrieve]
11. Fink M, Duprat F, Lesage F, Reyes R, Romey G, Heurteaux C, Lazdunski M. Cloning, functional expression and brain localization of a novel unconventional outward rectifier K+ channel. EMBO J. 1996; 15: 6854–6862.[Medline] [Order article via Infotrieve]
12. Chemin J, Patel AJ, Duprat F, Lauritzen I, Lazdunski M, Honore E. A phospholipid sensor controls mechanogating of the K+ channel TREK-1. EMBO J. 2005; 24: 44–53.[CrossRef][Medline] [Order article via Infotrieve]
13. Lopes CM, Rohacs T, Czirjak G, Balla T, Enyedi P, Logothetis DE. PIP2 hydrolysis underlies agonist-induced inhibition and regulates voltage gating of two-pore domain K+ channels. J Physiol. 2005; 564: 117–129.
14. Maingret F, Patel AJ, Lesage F, Lazdunski M, Honore E. Lysophospholipids open the two-pore domain mechano-gated K+ channels TREK-1 and TRAAK. J Biol Chem. 2000; 275: 10128–10133.
15. Patel AJ, Honore E, Maingret F, Lesage F, Fink M, Duprat F, Lazdunski M. A mammalian two pore domain mechano-gated S-like K+ channel. EMBO J. 1998; 17: 4283–4290.[CrossRef][Medline] [Order article via Infotrieve]
16. Maingret F, Patel AJ, Lesage F, Lazdunski M, Honore E. Mechano- or acid stimulation, two interactive modes of activation of the TREK-1 potassium channel. J Biol Chem. 1999; 274: 26691–26696.
17. Maingret F, Lauritzen I, Patel AJ, Heurteaux C, Reyes R, Lesage F, Lazdunski M, Honore E. TREK-1 is a heat-activated background K+ channel. EMBO J. 2000; 19: 2483–2491.[CrossRef][Medline] [Order article via Infotrieve]
18. Murbartian J, Lei Q, Sando JJ, Bayliss DA. Sequential phosphorylation mediates receptor- and kinase-induced inhibition of TREK-1 background potassium channels. J Biol Chem. 2005; 280: 30175–30184.
19. Koh SD, Monaghan K, Sergeant GP, Ro S, Walker RL, Sanders KM, Horowitz B. TREK-1 regulation by nitric oxide and cGMP-dependent protein kinase. An essential role in smooth muscle inhibitory neurotransmission. J Biol Chem. 2001; 276: 44338–44346.
20. Sandoz G, Thummler S, Duprat F, Feliciangeli S, Vinh J, Escoubas P, Guy N, Lazdunski M, Lesage F. AKAP150, a switch to convert mechano-, pH- and arachidonic acid-sensitive TREK K+ channels into open leak channels. EMBO J. 2006; 25: 5864–5872.[CrossRef][Medline] [Order article via Infotrieve]
21. Patel AJ, Honore E, Lesage F, Fink M, Romey G, Lazdunski M. Inhalational anesthetics activate two-pore-domain background K+ channels. Nat Neurosci. 1999; 2: 422–426.[CrossRef][Medline] [Order article via Infotrieve]
22. Bockenhauer D, Zilberberg N, Goldstein SA. KCNK2: reversible conversion of a hippocampal potassium leak into a voltage-dependent channel. Nat Neurosci. 2001; 4: 486–491.[Medline] [Order article via Infotrieve]
23. Maingret F, Honore E, Lazdunski M, Patel AJ. Molecular basis of the voltage-dependent gating of TREK-1, a mechano- sensitive K+ channel. Biochem Biophys Res Commun. 2002; 292: 339–346.[CrossRef][Medline] [Order article via Infotrieve]
24. Garry A, Fromy B, Blondeau N, Henrion D, Brau F, Gounon P, Guy N, Heurteaux, Lazdunski M, Saumet JL. Altered acetylcholine, bradykinin and cutaneous pressure-induced vasodilation in mice lacking the TREK1 potassium channel: the endothelial link. EMBO J. 2007; 8: 354–359.[CrossRef]
Related Article:
Circ. Res. 2007 101: 176-184.
This article has been cited by other articles:
![]() |
E. E. Lloyd, S. P. Marrelli, and R. M. Bryan Jr. cGMP does not activate two-pore domain K+ channels in cerebrovascular smooth muscle Am J Physiol Heart Circ Physiol, June 1, 2009; 296(6): H1774 - H1780. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |